Catalyst Pharmaceuticals, Inc.

AMERIPRISE FINANCIAL INC CPRX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

215,922

Value ($000)

5,040

Weight

0.0%

2020 Q2 - 2025 Q4 (22 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	5,040	0.0%	215,922	12/31/2025
2025 Q3	11/14/2025	4,782	0.0%	242,722	9/30/2025
2025 Q2	8/14/2025	5,428	0.0%	250,149	6/30/2025
2025 Q1	5/14/2025	6,528	0.0%	269,178	3/31/2025
2024 Q4	2/14/2025	5,903	0.0%	282,834	12/31/2024
2024 Q3	11/14/2024	5,520	0.0%	277,657	9/30/2024
2024 Q2	8/14/2024	4,910	0.0%	316,975	6/30/2024
2024 Q1	5/15/2024	6,079	0.0%	381,350	3/31/2024
2023 Q4	2/14/2024	7,602	0.0%	452,235	12/31/2023
2023 Q3	11/14/2023	4,872	0.0%	416,759	9/30/2023
2023 Q2	8/14/2023	5,873	0.0%	436,968	6/30/2023
2023 Q1	5/22/2023	7,548	0.0%	455,239	3/31/2023
2022 Q4	2/14/2023	11,846	0.0%	636,741	12/31/2022
2022 Q3	11/14/2022	7,985	0.0%	622,355	9/30/2022
2022 Q2	8/15/2022	1,460	0.0%	208,321	6/30/2022
2022 Q1	5/16/2022	1,633	0.0%	197,080	3/31/2022
2021 Q4	2/14/2022	3,647	0.0%	538,859	12/31/2021
2021 Q3	11/15/2021	324	0.0%	61,027	9/30/2021
2021 Q1	5/17/2021	50	0.0%	10,955	3/31/2021
2020 Q4	2/12/2021	37	0.0%	10,955	12/31/2020
2020 Q3	11/16/2020	86	0.0%	28,866	9/30/2020
2020 Q2	8/14/2020	124	0.0%	26,792	6/30/2020